Substance use problems and disorders among adults 50 years and older receiving mental health treatment for a primary neurocognitive disorder.

IF 2.8 3区医学 Q3 GERIATRICS & GERONTOLOGY

Aging & Mental Health Pub Date : 2024-10-01 Epub Date: 2024-03-27 DOI:10.1080/13607863.2024.2335396

Orrin D Ware, Sol Baik, Todd D Becker, Hannah Neukrug, Sheryl Zimmerman

{"title":"Substance use problems and disorders among adults 50 years and older receiving mental health treatment for a primary neurocognitive disorder.","authors":"Orrin D Ware, Sol Baik, Todd D Becker, Hannah Neukrug, Sheryl Zimmerman","doi":"10.1080/13607863.2024.2335396","DOIUrl":null,"url":null,"abstract":"Objectives: This study sought to (1) identify the percentage of high-risk substance use or substance use disorder (SUD) and (2) examine the factors associated with high-risk substance use or SUD in adults aged 50 years and older receiving mental health treatment with a primary delirium or dementia diagnosis.Method: This study used 7 years (2013-2019) of national administrative data on community mental health center patients aged 50 years and older with a primary delirium or dementia diagnosis receiving treatment in the United States (U.S.). To examine factors associated with the dependent variable (high-risk substance use or SUD), a multivariable binary logistic regression model was utilized.Results: The sample included 77,509 individuals who were mostly aged 65 years and older (69.7%), and did not have co-occurring high-risk substance use or SUD (90.1%). Receiving treatment in a U.S. region other than the Northeast, being younger, male, not non-Hispanic White, and having multiple mental health diagnoses had greater odds of co-occurring high-risk substance use or SUD.Conclusion: One in ten persons in this sample having high-risk substance use or SUD highlights the clinical necessity for screening and subsequent treatment for co-occurring high-risk substance use among persons receiving treatment for a neurocognitive disorder.","PeriodicalId":55546,"journal":{"name":"Aging & Mental Health","volume":" ","pages":"1351-1356"},"PeriodicalIF":2.8000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Aging & Mental Health","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/13607863.2024.2335396","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/3/27 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"GERIATRICS & GERONTOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Objectives: This study sought to (1) identify the percentage of high-risk substance use or substance use disorder (SUD) and (2) examine the factors associated with high-risk substance use or SUD in adults aged 50 years and older receiving mental health treatment with a primary delirium or dementia diagnosis.

Method: This study used 7 years (2013-2019) of national administrative data on community mental health center patients aged 50 years and older with a primary delirium or dementia diagnosis receiving treatment in the United States (U.S.). To examine factors associated with the dependent variable (high-risk substance use or SUD), a multivariable binary logistic regression model was utilized.

Results: The sample included 77,509 individuals who were mostly aged 65 years and older (69.7%), and did not have co-occurring high-risk substance use or SUD (90.1%). Receiving treatment in a U.S. region other than the Northeast, being younger, male, not non-Hispanic White, and having multiple mental health diagnoses had greater odds of co-occurring high-risk substance use or SUD.

Conclusion: One in ten persons in this sample having high-risk substance use or SUD highlights the clinical necessity for screening and subsequent treatment for co-occurring high-risk substance use among persons receiving treatment for a neurocognitive disorder.

查看原文本刊更多论文

因原发性神经认知障碍而接受心理健康治疗的 50 岁及以上成年人的药物使用问题和障碍。

研究目的本研究旨在：（1）确定高风险药物使用或药物使用障碍（SUD）的比例；（2）研究在接受精神健康治疗、主要诊断为谵妄或痴呆的 50 岁及以上成年人中，与高风险药物使用或药物使用障碍相关的因素：本研究使用了 7 年（2013-2019 年）的全国行政数据，对象是在美国（U.S. ）接受治疗的 50 岁及以上被诊断为原发性谵妄或痴呆的社区精神卫生中心患者。为了研究与因变量（高危物质使用或 SUD）相关的因素，采用了多变量二元逻辑回归模型：样本包括 77,509 人，他们的年龄大多在 65 岁及以上（69.7%），没有同时出现高危药物使用或 SUD（90.1%）。在美国东北部以外的地区接受治疗、年龄较小、男性、非非西班牙裔白人以及被诊断出患有多种精神疾病的人有更高的几率同时合并高危药物使用或药物依赖性精神障碍：结论：在该样本中，每十人中就有一人患有高危药物滥用或药物依赖性精神障碍，这凸显了在接受神经认知障碍治疗的人群中筛查和治疗并发高危药物滥用的临床必要性。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Aging & Mental Health 医学-精神病学

CiteScore

7.00

自引率

2.90%

发文量

176

审稿时长

4-8 weeks

期刊介绍： Aging & Mental Health provides a leading international forum for the rapidly expanding field which investigates the relationship between the aging process and mental health. The journal addresses the mental changes associated with normal and abnormal or pathological aging, as well as the psychological and psychiatric problems of the aging population. The journal also has a strong commitment to interdisciplinary and innovative approaches that explore new topics and methods. Aging & Mental Health covers the biological, psychological and social aspects of aging as they relate to mental health. In particular it encourages an integrated approach for examining various biopsychosocial processes and etiological factors associated with psychological changes in the elderly. It also emphasizes the various strategies, therapies and services which may be directed at improving the mental health of the elderly and their families. In this way the journal promotes a strong alliance among the theoretical, experimental and applied sciences across a range of issues affecting mental health and aging. The emphasis of the journal is on rigorous quantitative, and qualitative, research and, high quality innovative studies on emerging topics.